A widely used gasoline additive, methyl tertiary butyl ether (MTBE), has been controversial, in part because of concerns about potential inhalation health effects and more recently because of added concerns about water contamination. Although many of the issues related to MTBE have not been fully resolved, several apparent paradoxes can be discerned, including the fact that something intended to improve air quality is now seen as a threat to water quality. Among the lessons that can be derived from the MTBE experience is the value of a comprehensive understanding of the potential risk-benefit tradeoffs of different fuels and fuel additives.
Methyl tertiary butyl ether (MTBE, see Fig. 1 ) is a gasoline additive that has been the subject of much controversy. Originally introduced into the U.S. fuel supply in the late 1970s to help take the place of tetraethyl lead by increasing the octane rating of gasoline, MTBE became more widely used as an oxygenate after the Clean Air Act Amendments of 1990 required gasoline with a minimum oxygen content in certain metropolitan areas with high ambient air levels of carbon monoxide (CO) or ozone (O 3 ). The federal requirements do not specify any particular oxygenate, but because MTBE was a relatively inexpensive means of adding oxygen to gasoline, and because it had other favorable properties as a fuel additive, MTBE became the dominant oxygenate in the U.S. fuel market, with ethanol in distant second place. According to the U.S. Environmental Protection Agency (U.S. EPA, 2000) , MTBE has accounted for about 90% of oxygenates used in reformulated gasoline (RFG), which is sold year-round in areas trying to meet the ozone ambient air standards. Currently, RFG constitutes approximately 30% of the U.S. gasoline market. Much smaller amounts of MTBE are used for octane alone and for winter fuels in areas with CO air quality problems. Altogether, roughly a third of U.S. gasoline has had some amount of MTBE in it in recent years.
Congress required the use of oxygenates in gasoline for various reasons, but one expectation was that oxygenates would reduce harmful emissions from motor vehicles, specifically CO, precursors of ozone, and certain toxic air pollutants such as benzene. Nevertheless, unintended consequences have raised serious questions about the suitability of MTBE as a fuel additive. First, some consumers reported health symptoms associated with acute exposure to MTBE vapors from refueling or vehicle emissions. Other health concerns, especially the risk of cancer from long-term exposure, have also been an issue. In addition to inhalation health risks, concerns about water contamination have become prominent with the growing evidence of MTBE in ground water, due to gasoline leaking from underground fuel-storage tanks and other sources. In contrast to other gasoline constituents, MTBE is more water soluble and generally resistant to biodegradation, and consequently can be found in ground water separate from gasoline itself. This contamination of water resources has intensified the public's concerns about MTBE health risks and raised new issues about MTBE impacts on the taste and odor of drinking water.
Health Risks of MTBE
As the volume of MTBE usage increased during the 1980s with the phase-out of lead in gasoline, EPA took steps to see that more extensive toxicity testing of MTBE was conducted. Until then, most of the toxicity information had come from unpublished laboratory reports. In 1987, EPA initiated actions under the Toxic Substances Control Act (TSCA) to establish a legally enforceable consent agreement with MTBE manufacturers. Under this agreement, the industry would support several toxicity studies, including 2-year inhalation bioassays with
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1 To whom correspondence should be addressed at NCEA/ORD (MD-52), U.S. Environmental Protection Agency, Research Triangle Park, NC 27711. Fax: (919) 541-0245. E-mail: Davis.Jmichael@epa.gov. TOXICOLOGICAL SCIENCES 61, 211-217 (2001) laboratory rats and mice, as well as standard tests of neural, reproductive, or developmental toxicity, and mutagenesis (Duffy et al., 1992) . The testing was performed primarily by inhalation exposure rather than by ingestion, because the most prevalent route of human exposure was thought to be inhalation.
In 1991, EPA used the data available from these studies to derive an inhalation reference concentration (RfC). The RfC is defined as an estimate (with uncertainty spanning about an order of magnitude) of a continuous inhalation exposure level for the human population (including sensitive subpopulations) that is likely to be without appreciable risk of deleterious non-cancer effects during a lifetime. After additional data on the effects of chronic exposures became available in late 1992, the initial RfC of 0.5 mg/m 3 was revised to 3 mg/m 3 , based on findings of increased liver and kidney weights and increased severity of spontaneous renal lesions in female rats, as well as increased prostration in females and swollen periocular tissue in male and female rats (IRIS, 1993) . When this value of 3 mg/m 3 was compared with "worst case" chronic inhalation exposure scenarios, yielding time-weighted average exposure levels of less than 0.2 mg/m 3 MTBE, it appeared unlikely that the general population would be at appreciable risk of noncancer health effects from MTBE (U.S. EPA, , 1994 . Subsequent reviews and assessments by other organizations (Health Effects Institute, 1996; Interagency Oxygenated Fuels Assessment Steering Committee, 1997; NRC, 1996) have been consistent with this conclusion.
Other questions about the health risks of MTBE have been more contentious, particularly with respect to the potential for acute health effects and for carcinogenicity from longer-term exposure. The issue of acute health effects arose soon after the introduction of the oxygenated gasoline program in the fall of 1992. Complaints of headache, nausea, eye and nose irritation, and other symptoms began to be reported in Fairbanks, Alaska and some other locales where the new oxygenated winter fuel was being used. In response, several studies were initiated to investigate the basis for such symptom reports. Some of these studies were conducted in communities where people were likely to be exposed to oxygenated gasoline (e.g., Mohr et al., 1994; White et al., 1995) , and some were performed under controlled experimental inhalation conditions with either human volunteers or laboratory animals (e.g., Cain et al., 1996; Johanson et al., 1995; Prah et al., 1994; Tepper et al., 1994) . Although the presence of the additive or one of its metabolites, tertiary butanol (TBA), could confirm exposure to MTBE in blood, an association between exposure indicators and symptoms or signs could not be clearly established. In short, no basis could be determined for the acute symptoms that had been reported, but the possibility that some individuals were especially sensitive to MTBE could not be ruled out.
Subsequent attempts to investigate self-described sensitive individuals under controlled laboratory conditions have met with mixed success. Even recruiting complainants for participation in controlled-exposure studies has been difficult (Fiedler et al., 2000; Prah, personal communication) . Fiedler et al. (2000) have reported the only study to date that has evaluated the responses of self-reported sensitive (SRS) subjects under controlled conditions. Twelve SRS subjects were compared with 19 control subjects under four exposure conditions: clean air, gasoline alone, gasoline with 11%-vol MTBE, and gasoline with 15%-vol MTBE. The two concentrations of MTBE corresponded to the levels that have typically been used in winter fuels for CO control (15%-vol) and in reformulated gasoline for ozone control (11%-vol), with the exposure concentrations approximating documented exposures during refueling. Compared with control subjects, the SRS subjects reported significantly more symptoms of all types (including some not previously associated with complaints about MTBE) under all conditions, including clean air. Other than these subjective responses, the SRS and control subjects did not differ on neurobehavioral or physiological endpoints or in their ratings of the odors of the exposure conditions. However, the SRS subjects did report significantly more symptoms (but no other objective response measure) when exposed to 15%-vol MTBEgasoline than to clean air or, for that matter, 11%-vol MTBEgasoline. Thus, it can be argued that SRS subjects were indeed shown to be more "sensitive" to 15%-vol MTBE-gasoline and that this differential symptom response was not mediated by their ability to discriminate the different conditions by odor. On the other hand, it can also be argued that the lack of difference in symptom reports between 11%-vol MTBE-gasoline and gasoline alone (or even clean air) shows there may be "no problem," even for these SRS individuals, with MTBEoxygenated reformulated gasoline, which constitutes the vast majority of the current U.S. usage of MTBE. But generalizing from such a small sample of subjects is problematic, so it is not likely that the debate on acute health effects can be resolved on the basis of this study.
The cancer risk of MTBE is also still unresolved. Three long-term studies have been conducted with laboratory rodents, two by inhalation in rats and mice (Bird et al., 1997) and one by gavage in rats (Belpoggi et al., 1995 (Belpoggi et al., , 1998 . The inhalation study showed an increased incidence of testicular 3 . An increased incidence of hepatocellular adenomas was observed in female CD-1 mice at 28,800 mg/m 3 . In Sprague Dawley rats given MTBE in olive oil by gavage at 0, 250, or 1000 mg/kg bw, females had an increased incidence of lymphomas and leukemia, and males had an increased incidence of testicular interstitial cell adenomas. In addition, two major metabolites of MTBE, namely TBA and formaldehyde, have shown evidence of carcinogenicity (Cirvello et al., 1995; IRIS, 1991) .
These findings have been the ongoing subject of extensive evaluation and debate. To illustrate briefly the type of issues in contention, the finding of kidney tumors observed in male rats exposed to MTBE by inhalation (Bird et al., 1997) has been questioned as to the relevance to human cancer risk because of the role the male rat-specific protein alpha-2u-globulin (␣-2u) has been found to play in inducing kidney tumors in male rats. Borghoff and her colleagues (Borghoff et al., 1996; Borghoff and Williams, 2000; Poet and Borghoff, 1997; Prescott-Matthews et al., 1997) have amassed several lines of evidence that ␣-2u mediates the formation of male rat kidney tumors from MTBE. However, the relationship between MTBE-induced ␣-2u accumulation and renal cell proliferation is not fully understood, because the proliferative response is disproportional to the relatively weak ␣-2u response to MTBE. This disproportion leaves open the possibility that some other nonspecies-specific mode of action could also figure into the induction of male rat kidney tumors. Expert advisory groups have had mixed judgments on human cancer risk based on this and other evidence of MTBE-induced tumors in laboratory rodents. Some evaluations (e.g., California EPA, 1999; Interagency Oxygenated Fuels Assessment Steering Committee, 1997; U.S. EPA, 1994) have concluded that MTBE could pose a possible or potential cancer risk to humans, whereas other public health bodies (e.g., IARC, 1998; U.S. Department of Health and Human Services, 2000; World Health Organization, 1998) have concluded that there is not enough information to classify MTBE with regard to human carcinogenicity under their classification schemes. The U.S. EPA plans to formally evaluate carcinogenicity and other health issues for its Integrated Risk Information System (IRIS) and to update, if necessary, the Agency's consensus opinion on MTBE health hazards and potential risks.
Sensory Characteristics
While debates continue regarding the potential health risks of MTBE, concerns about the odor and taste of water contaminated by MTBE have generally played a more prominent role in actions at the local, state, and federal levels. When compared with many other common chemicals, the odor detection threshold for MTBE is relatively low (averages in water have been reported to range from 15 to 180 g/l) (Dale et al., 1997; Malcolm Pirnie, 1998; Prah et al., 1994; Shen et al., 1997b; Vetrano, 1993; Young et al., 1996) , with some individual thresholds below 5 g/l (Shen et al., 1997b) . By comparison, the odor threshold for benzene, for example, is about 10-fold higher (Young et al., 1996) . Moreover, the odor and taste of MTBE have been frequently characterized as very offensive (e.g., Angle, 1991; Vetrano, 1993) . Based on the taste and odor characteristics of MTBE, EPA issued an advisory that suggested consumer acceptability of drinking water could be maintained if concentrations were at or below 20 -40 g/l, recognizing that some individuals could detect the chemical at levels below this range (U.S. EPA, 1997) .
The State of California has both a primary, health-based standard for MTBE and a secondary standard based on taste and odor properties. The primary standard is 13 g/l, and the secondary standard is 5 g/l (California EPA, 1999) . The fact that the California primary standard is higher than the secondary standard reflects a view that available health effects information does not suggest that MTBE is likely to pose as much of a risk to public health as an offense to the senses or sensibilities (see also U.S. EPA, 1997). This is not to say that a foul odor or taste is necessarily any less "real" than a health risk. Confronted with an unusual taste or odor, people may understandably be fearful that their water is tainted. They might also go to some expense or effort to treat the water, replace it, or otherwise avoid using it. These public welfare issues are recognized as a valid basis for setting secondary MCLs to protect the odor or appearance of water, as EPA has done for several substances, including copper, iron, sulfates, and zinc, and is considering doing for MTBE.
Although published and anecdotal reports frequently describe the taste and odor of MTBE in strongly aversive terms, a statistically representative sampling of population responses to the taste and odor of MTBE in water has not been reported. The sensory threshold studies that have been conducted to date on MTBE have, for the most part, been conducted with small numbers of experienced or trained individuals as a panel of subjects. The results of such studies may be useful for public water suppliers to determine a level of contamination at which their clients might detect or object to the presence of MTBE in their water. However, such data are not likely to be representative of the range of sensitivities and reactions present in the population as a whole, which is known to include a substantial number of hyposmic and anosmic individuals. Thus, the general population is likely to be described by a distribution that includes not only individuals with very low thresholds but those who have little or no sense of taste or smell. Apart from the minimum concentration for detection or recognition, other dimensions of odor or taste include the intensity, character, and hedonic quality of the experience (U.S. EPA, 1992b) . Limited data suggest a range of responses to MTBE in these dimensions as well: along with descriptors such as bitter, nasty, and solvent-or plastic-like, the terms "sweet" and "vanilla-like" have sometimes been applied to MTBE in drinking water (Dale et al., 1997; Young et al., 1996) . Moreover, Dale et al. (1997) reported that a panel of four trained analysts, when presented with samples of MTBE in odor-free water at concentrations of approximately 2, 5, 20, 50, 100 g/l and higher, could detect MTBE at levels as low as 2-5 g/l, but did not consider the intensity of the sensory experience "objectionable" until a concentration of approximately 50 g/l for taste or 90 -100 g/l for odor was reached.
The implications of such varied reactions are interesting. One implication is pertinent to the notion that MTBE acts as an "early warning" signal that water is contaminated with gasoline and thus serves to reduce or avert human exposure to harmful gasoline constituents such as benzene. This supposed early warning benefit is sometimes offered as a defense of MTBE, but the argument is not very compelling when one considers the broad range of sensory acuity (or lack thereof) in a normal population. Even individuals with average sensory abilities might regularly ingest MTBE-contaminated water for many reasons, including the fact that substances such as disinfection chemicals could mask the taste or odor (Shen et al., 1997a) .
When individuals or groups of persons seem to differ considerably in their sensitivity or reaction to a stimulus, such divergence may reflect more than variability in physiological response. Dalton (1996) has shown that cognitive factors can significantly influence the perception of an odor. In one experiment, subjects were given the information that a substance was either (1) a natural extract reported to have positive effects on mood and health (positive condition), (2) an industrial solvent reported to cause problems with health and cognition (negative condition), or (3) a standard odorant approved for olfactory research (neutral condition). The subjects' ratings of the intensity of the odor varied according to the type of information they were provided before the exposure. The positive group showed a typical pattern of adaptation in which intensity ratings declined over time, whereas, the negative group showed an initial adaptation that reversed after a few minutes and was replaced by increasing intensity ratings, i.e., sensitization to the odor. The neutral group was intermediate in response. In addition, spontaneous reports of headache, lethargy, dizziness, and irritation were registered by 11 of the 15 subjects in the negative group and 2 of 15 in the neutral group, but by none in the positive group.
The importance of odor and contextual information is also suggested by the results of a study conducted in response to adverse public reaction to RFG when it was first introduced in Milwaukee (Anderson et al., 1995) . Residents of three areas were randomly surveyed by telephone: Milwaukee, where about 50% of the RFG was oxygenated with MTBE; Chicago, which had RFG from the same distribution network as Milwaukee; and other areas of Wisconsin, where RFG was not required. Reports of symptoms previously associated with oxygenated gasoline (headache, dizziness, nausea), as well as unrelated symptoms (backache, fever), were significantly higher among Milwaukee respondents (23%) than among those in either Chicago or non-RFG areas of Wisconsin (6% each).
Having had a cold or the flu was the strongest predictor of reporting symptoms attributed to RFG among Milwaukee respondents, but not among Chicago or Wisconsin respondents; yet all three areas had similar rates of colds and flu that season. Another key factor associated with the higher prevalence of symptom reporting was awareness of RFG, which was greater in Milwaukee, due in part to substantial local media coverage of RFG issues. Respondents who indicated that they had purchased RFG were also more likely to report "unusual smells" from the gasoline than those who said they had not purchased RFG or did not know what type of fuel they had bought. Thus, it appears that "many symptoms reported by Milwaukee residents may have actually been due to colds or flu and not RFG exposure," and that "knowledge about RFG, including ". . . potential negative effects . . . , may have heightened perception of current health status and resulted in the assumption that any health symptoms experienced were unusual and attributable to gasoline exposure" (Anderson et al., 1995) .
Lessons Learned
More information will be needed before all the scientific debates about MTBE can be definitively settled. The current weight of evidence appears to be tipping in the direction of reducing or eliminating the use of MTBE because of the threat it can pose to water resources (Federal Register, 2000) . However the MTBE story ultimately plays out, it may be instructive to consider whether alternative courses of action to date might have produced different outcomes.
Without necessarily concluding that MTBE is a public health threat, some commentators have nonetheless asserted that this additive should have been evaluated much more thoroughly before being introduced on such a wide scale into the U.S. fuel supply (Goldstein and Erdal, 1999) . As it applies to the first introduction of MTBE in the late 1970s, when toxicity information on MTBE was extremely limited, the criticism seems quite apropos. Indeed, it was several years later before EPA issued a rule, as mandated by section 211(b) of the Clean Air Act, to require toxicity testing of fuels and fuel additives (Federal Register, 1994) . Nevertheless, by late 1992-when the first federally mandated oxygenated fuel program began and MTBE usage increased considerably-a substantial amount of toxicity data had in fact been obtained under the TSCA enforceable consent agreement between EPA and MTBE manufacturers. These studies have since been published as several articles in a supplement to the Journal of Applied Toxicology, 17(S1): S1-64, 1997).
One could argue that there were clues in the available data from the TSCA testing and other sources that were not heeded. Given the types of neurobehavioral effects (ataxia, hypoactivity, and other signs of reversible CNS depression) observed in laboratory rodents exposed to high (Ͼ10,000 mg/m 3 ) concentrations of MTBE, and given the history of human experience with other ethers (e.g., diethyl ether, at one time used as a general anesthetic), would not one expect the types of symptoms (headache, eye and nose irritation, nausea, dizziness, lethargy) that some people reported after the introduction of oxygenated fuels? One problem with this observation is that, despite some qualitatively similar CNS depressant effects, such effects had been observed in rodents (and perhaps surgery patients) only at exposure levels several orders of magnitude higher than were thought likely to occur in general population exposures. Even the no-observed-effect levels (2880 -14,400 mg/m 3 ) for these types of effects were orders of magnitude higher than observed environmental levels. Moreover, there had been little indication of adverse public reaction to MTBEoxygenated gasoline in smaller scale fuel programs such as the ones in Denver and Phoenix during the late 1980s .
However, rodents might not be considered an adequate model for the type of effects some people experienced. After all, "rats don't retch," so how would their reactions predict nausea in humans? Still, at least one attempt to discover evidence of respiratory irritancy, using a standard testing method for mice, showed little indication that MTBE vapor was relatively irritating (Tepper et al., 1994) ; moreover, inhalation testing with human volunteers showed little evidence of an irritancy effect (Cain et al., 1996; Johanson et al., 1995; Prah et al., 1994) . Perhaps the testing should have been done with a mixture of gasoline and MTBE, not MTBE alone? Yet epidemiologic studies (Mohr et al., 1994; White et al., 1995) did not confirm a significant incidence of health symptoms in individuals exposed to real-world mixtures of gasoline and MTBE. Nevertheless, if the segment of the population that experiences symptoms is relatively small, such studies would probably not have enough power to detect the effects. But the study of self-reported sensitive individuals described above (Fiedler et al., 2000) , while substantiating the existence of individuals who are relatively more sensitive to 15%-vol MTBE-gasoline, does not corroborate the symptoms attributed to RFG with 11%-vol MTBE.
After all of these "on-the-one-hand" and "on-the-other" points have been laid out, one comes down to the basic conundrum of how much testing should have been done to anticipate the kind and prevalence of symptoms that surfaced with the oxygenated gasoline programs. If the percentage of physiologically sensitive individuals in the general population is quite small, it seems unlikely that even much more extensive animal toxicity testing would have predicted the extent or severity of their reactions. Despite substantial efforts directed at investigating acute-symptom reports (Fiedler et al., 2000; U.S. EPA, 1995) , the basis for these complaints has yet to be adequately elucidated. Given this current state of the science, one must question whether the course of events, as they unfolded in the 1990s, would have been altered even if the TSCA testing had been completed in the mid-1970s (before any use of MTBE), or even if the more extensive animal and human testing performed in the 1990s had been performed earlier.
None of this discussion is meant to imply that it makes no difference whether a substance to which several million people are daily exposed is adequately evaluated before its widespread use. Clearly, it is important, and the authority to require such testing under Section 211(b) of the Clean Air Act is evidence of the importance that Congress attached to such evaluation. However, the limits of such testing for detecting the types of problems that have arisen with MTBE should be seen as a cautionary note for toxicologists and risk assessors: do not be overly confident in the ability of standard toxicity testing to predict or avert health issues in the general population. Actually, in this case, the limitations of the tests themselves may not have been the primary problem; rather, the attempt to focus the testing in a manner that seemed rational and efficient at the time ended up missing or being unable to address the concerns that subsequently emerged. Whereas the TSCA testing program was directed at the inhalation toxicity of MTBE vapors alone, when public concerns surfaced about oxygenated gasoline it became obvious that more information was needed on the mixture of MTBE and gasoline (U.S. EPA, 1996) . Then, as concerns arose about groundwater contamination and possible drinking water exposure to MTBE, attention turned back to neat MTBE-but by the oral route, not by inhalation (U.S. EPA, 1998) .
Among the many paradoxes surrounding MTBE, one of the most obvious is that something that was intended to improve environmental quality has ended up being widely viewed as an environmental threat (Greenbaum, et al. 1999) . Possibly the most valuable lesson to be gained from the MTBE experience may be the importance of obtaining a comprehensive understanding of the many and varied risks and benefits potentially offered by any given fuel option. This should entail a consideration of all facets of the life cycle of a fuel or additive, including the environmental fate of any emissions or releases, because the by-products of a chemical may be of greater toxicological or environmental significance than the parent compound itself. Moreover, the potential for exposure of human populations and ecosystems needs to be understood in terms of multi-media, multi-pathway cumulative exposures. Finally, no fuel option exists in a vacuum. It is not simply a question of whether MTBE is "good" or "bad," but whether its trade-offs are better or worse than the trade-offs presented by the alternative(s), e.g., conventional gasoline or RFG containing a different oxygenate or, possibly, no oxygenate at all (Franklin et al., 2000) .
Ironically, several years ago the U.S. EPA laid out a strategy for obtaining comprehensive information on the risks and benefits of fuels and additives, including MTBE. Among other things, the strategy called for research to "assess the impact of reformulated gasolines on the potential for groundwater contamination and resultant pollutant exposure," and to "characterize the impacts of oxygenates on the fate and transport of fuel components" (U.S. EPA, 1992a) . Had these prescient statements been heeded more closely by industry or govern-ment, perhaps some of the paradoxes of MTBE would not have developed.
